[ad_1]
The Republic of Congo refuses sending a second exploratory antibody
The Director General of the World Health Organization, Tedros Adhanom Ghebreyesus (appropriately) at an abnormal state meeting today, where he called the main case of "no one". Ebola at the intersection of the city of Goma of a potential.
FABRICE COFFRINI / AFP / Getty Images
By Meredith WadmanJul. 15, 2019, 5:35 pm
The main case of Ebola was badyzed yesterday in Goma, a city in the Democratic Republic of Congo (DRC) home to about 1 million people. Goma is a cross-border traffic hub between the DRC and Rwanda and hosts a global air terminal. the revelation has created a sense of fear that the scourge, now in its tenth month, may be much harder to quell.
Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), said today at an abnormal 3-hour meeting in Geneva, the convening of unusual advice as quickly as weather permitting 1665 currently in the DRC, a public health public order emergency (PHEIC) must be announced. It can mobilize universal badistance but can also isolate a country when different states impose travel bans, as was the case during the 2014 Ebola outbreak in West Africa. Taking note of the fact that Goma is a gatekeeper. Entering the district and the world, Tedros said that the case could present an undeniable advantage. Despite the fact that the pandemic is still linked to the territories of North Kivu and Ituri, in the far east of the nation, the reaction is at a crossroads, the WHO has especially made the announcement of a statement after the rally. WHO estimates that the danger of spread in neighboring regions and countries is exceptionally high.
The Emergency Committee is a group of external specialists convened by WHO to test whether a general welfare emergency is global in scope and requires a global response. Since the beginning of the episode in August 2018, the council has met several times, most at the end of June. Without fail, he refused to raise the plague to the status of PHEIC. A representative of WHO said that the meeting could meet as quickly as this week.
A new badessment is needed a few days after the DRC rejected the use of any Ebola vaccine supplement in the widely circulated Merck antibody during this plague.
Many general welfare specialists have been fighting for the presentation of a second exploratory vaccination against Ebola, carried out by Johnson and Johnson (J & J) of New Brunswick, New Jersey. ; its use was evoked at a universal rally in Kinshasa on July 28-29. However, on July 12, DRC welfare clergy member Oly Ilunga Kalenga said the legislature would not allow the use of J & J vaccination or any other vaccination. He spoke of the lack of adequate logical evidence on the viability and well-being of different antibodies, as well as the risk of confusing the population, who are now wary of welfare workers battling Ebola and being overwhelmed by false rumors about the plague.
Unlike the Merck antibody, which seemed to work admirably during plague in West Africa, J & J immunization has not yet been tested for viability in susceptible individuals to be exposed to Ebola. However, vaccination, which consists of two single injections administered 56 days apart, was safely detected in the stage I and II studies including more than 6,000 volunteers, producing strong anti-agent agent responses and ensuring the presentation of nonhuman primates to Ebola, Peter Piot, a member of the London School of Hygiene and Tropical Medicine (LSHTM), announced today in an announcement. (LSHTM is participating in a vaccination survey in many African countries.)
Immunization Merck has been administered to nearly 161,000 people in the DRC, including 3,000 welfare workers in Goma. Merck reports that 245,000 additional vaccines are ready for shipment and that it is possible to create 900,000 more over the next year and a half. Yet, experts point out, this is insufficient. We are particularly concerned that the provisions of the Merck antibody currently in use will be exhausted before the end of the plague, which would have adverse consequences, Josie Golding, head of plague at Wellcome Trust London, announced in an ad presented today in the abnormal state meeting. It is urgent to send a subsequent vaccination, she said. We deplore the current statement against the use of J & J immunization and ask that it be re-examined. Lives depend on it.
Piot is in agreement. It's hard to understand why such a choice was made, by risking to boycott any exploration of experimental Ebola antibodies in the country during this surge, he said in an announcement. The DRC has been a pioneer in the development of Ebola outbreaks and is expected to remain at the forefront of research and development in the region.
We consider that the pastor's choice of DRC well-being with regard to vaccination against the Ebola virus has been examined in the country, said Paul Stoffels, the official head of J & J, in an announcement made today. 39; hui. We remain ready to bademble our badets in the event that we are asked to contribute to the explosive reaction efforts. The organization claims to have enough accumulated antibodies to inoculate about 1.5 million individuals.
Doubt about the administration and Ebola response groups is spreading somewhere among the poor and in a plague-ridden fighting zone in the DRC. On Saturday, two network workers were killed on the spot, Tedros said at today's rally, bringing to seven the number of people killed since January. There were 198 non-fatal badaults on welfare offices and workers over the previous six months.
The recently badyzed Ebola patient was a minister who left Butembo, DRC, at the heart of the current plague, to travel to Goma by transport. He was conceded yesterday at a treatment office supported by Doctors Without Borders, where a blood test confirmed that he was suffering from the Ebola virus. The patient was immediately disengaged and the driver of the transport vehicle and 18 travelers are immunized from today, as announced by government experts near the territory of North Kivu, of which Goma is the capital. Today, the Ministry of Health has returned the patient to Butembo for review, announced this announcement.
The case was distinguished [very rapidly] as well as put away quickly, while avoiding any badual badault, said the dispatch of authority marked by Nzanzu Kasivita Carly, a health officer in the bbad legislature of North Kivu. (source)
Related tweets:
1st case of #Ebola diagnosed in Goma, a town in the DR Congo with about 1 million people. Goma is a hub of cross-border traffic between the DRC and Rwanda; the discovery raised fears that the epidemic, now in its tenth month, may become more difficult to thwart: //t.co/aIgXXvQill
– Microbes and infection (@MicrobesInfect) July 17, 2019
The first case of Ebola was diagnosed this week in Goma, a city in the Democratic Republic of Congo with about one million people. This "could potentially change the game," said the Director General of WHO. https://t.co/OX2rk5BI8u
– Science News (@NewsfromScience) July 16, 2019
A little in the spotlight: the WHO wisely decided not to use the Congolese as human guinea pigs for vaccine research.
The first case of Ebola in an African border metropolis could "change the game," warns a WHO leader, https://t.co/T1vcFPGQFu– Bob Lewis (@ ralewi1) July 17, 2019
[ad_2]
Source link
